Lawsuit Overview
May 08, 2012 (Shareholders Foundation) -- An investor in NASDAQ: GPRO shares filed a lawsuit against directors in effort to block the proposed acquisition of Gen-Probe Incorporated by Hologic, Inc at $82.75 per share. The plaintiff alleges that defendants breached their firducayr duties owed to NASDAQ:GPRO stockholders arising out of the attempt to sell Gen-Probe Incorporated at an ...
You must register (for free) or login to view the entire case.